Clinical Trial Update: Study To Examine The Effects Of Lapatinib On The Pharmacokinetics Of Digoxin In Subjects w/ ErbB2 Positive Breast Cancer [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the effect of lapatinib on the pharmacokinetics of digoxin in subjects with ErbB2/HER2-positive breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DIGOXIN (Digoxin)
• Lapatinib (Lapatinib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Neoplasms, Breast | Phase 1 | Status: COMPLETED